Passage Bio

(NASDAQ) PASG

Current Price$6.08

Market Cap$19.63M

Since IPO (2020)-99%

5 Year-98%

1 Year-16%

1 Month+13%

Passage Bio Financials at a Glance

Market Cap

$19.63M

Revenue (TTM)

$0.00

Net Income (TTM)

-$37.68M

EPS (TTM)

-$11.84

P/E Ratio

-0.52

Dividend

$0.00

Beta (Volatility)

1.67 (High)

Dividend

$0.00

Beta (Volatility)

1.67 (High)

Price

$6.08

Volume

1,039,810

Open

$6.27

Price

$6.08

Volume

1,039,810

Open

$6.27

Previous Close

$5.88

Daily Range

$5.78 - $6.30

52-Week Range

$3.94 - $20.00

Estimated Earnings Date

Aug 11, 2026

Dividend

$0.00

Beta (Volatility)

1.67 (High)

Price

$6.08

Volume

1,039,810

Open

$6.27

Previous Close

$5.88

Daily Range

$5.78 - $6.30

52-Week Range

$3.94 - $20.00

Estimated Earnings Date

Aug 11, 2026

PASG News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Passage Bio

Industry

Biotechnology

Sector

Health Care

Employees

CEO

William Chou, MD, MBA

Website

www.passagebio.com

Headquarters

Philadelphia, PA 19103, US

PASG Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-150.88%

Return on Capital

-100.90%

Return on Assets

-103.33%

Earnings Yield

-1.92%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$19.63M

Shares Outstanding

3.21M

Volume

1.04M

Avg. Volume

78.90K

Financials (TTM)

Gross Profit

-$329.00K

Operating Income

-$41.72M

EBITDA

-$34.22M

Operating Cash Flow

-$30.65M

Capital Expenditure

$0.00

Free Cash Flow

-$30.65M

Cash & ST Invst.

$33.34M

Total Debt

$5.76M

Passage Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$129.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$19.63M

N/A

Market Cap/Employee

$327.20K

N/A

Employees

N/A

Net Income

-$7.56M

+50.9%

EBITDA

-$7.43M

+45.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$33.34M

-47.4%

Total Debt

$5.76M

-77.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$4.61M

-78.6%

Short Term Debt

$1.15M

-68.4%

Return on Assets

-1.03%

N/A

Return on Invested Capital

-2.55%

N/A

Free Cash Flow

-$12.99M

+6.2%

Operating Cash Flow

-$12.99M

+6.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ALLRAllarity Therapeutics, Inc.

ALLRAllarity Therapeutics, Inc.$1.30-1.52%

XCURExicure, Inc.

XCURExicure, Inc.$2.69-1.47%

ENLVEnlivex Therapeutics Ltd.

ENLVEnlivex Therapeutics Ltd.$0.61-0.93%

CINGCingulate Inc.

CINGCingulate Inc.$4.81-0.41%

GDTCCytoMed Therapeutics Limited

GDTCCytoMed Therapeutics Limited$0.99-1.98%

NCNANuCana plc

NCNANuCana plc$1.64-5.20%

LSTALisata Therapeutics, Inc.

LSTALisata Therapeutics, Inc.$3.44-0.86%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$131.65-0.00%

NOKNokia

NOKNokia$13.81+0.01%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$33.87-0.04%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.27+0.01%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$154.54-0.01%

ONDSOndas

ONDSOndas$7.68-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.30-0.01%

Questions About PASG

What is the current price of Passage Bio?

Passage Bio is trading at $5.88 per share.

What is the 52-week range for Passage Bio?

Over the past 52 weeks, Passage Bio has traded between $3.94 and $20.00.

How much debt does Passage Bio have?

As of the most recent reporting period, Passage Bio reported total debt of $5.76M.

How much cash does Passage Bio have on hand?

Passage Bio reported $33.34M in cash and cash equivalents in its most recent financial results.

What is Passage Bio’s dividend yield?

Passage Bio does not currently have a dividend yield.

Passage Bio

Passage Bio Financials at a Glance

PASG News

Here's Why Shares of Passage Bio Dropped Today

The Coronavirus Pandemic Will Delay 2020 IPOs

Gene Therapy Biotech Passage Bio IPOs

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Passage Bio

PASG Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Passage Bio Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PASG

What is the current price of Passage Bio?

What is the 52-week range for Passage Bio?

How much debt does Passage Bio have?

How much cash does Passage Bio have on hand?

What is Passage Bio’s dividend yield?

Premium Investing Services